Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAOA | P21397 | 7/20 | 0.40 |
| ▸ | MAOB | P27338 | 7/20 | 0.40 |
| ▸ | KDM1A | O60341 | 6/20 | 0.40 |
| ▸ | DPP4 | P27487 | 3/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.34 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6583918 | 0.74 | MAOA (0.43) | MAOAMAOBKDM1ADPP4OPRM1 | |
| SCHEMBL9852757 | 0.68 | MAOA (0.33) | LMNAMAOAMAOBKDM1ADPP4 | |
| SCHEMBL4678353 | 0.68 | MAOA (0.48) | MAOAMAOBKDM1ADPP4OPRM1 | |
| SCHEMBL4811682 | 0.67 | MAOB (0.38) | MAOAMAOB | |
| SCHEMBL1841591 | 0.67 | LMNA (0.46) | LMNAMAOAMAOBKDM1AALDH1A1 | |
| SCHEMBL25537260 | 0.66 | GRIN2B (0.46) | LMNAMAOAKDM1AOPRM1ALDH1A1 | |
| SCHEMBL10073907 | 0.66 | CTSC (0.43) | LMNA | |
| SCHEMBL9143256 | 0.65 | KDM1A (0.46) | LMNAMAOAMAOBKDM1ADPP4 | |
| SCHEMBL1722310 | 0.65 | KDM1A (0.50) | MAOAMAOBKDM1ADPP4OPRM1 | |
| SCHEMBL30958585 | 0.65 | MAOA (0.48) | LMNAMAOAMAOBKDM1AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2362765-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2011-09-07 | — | — | EP | claimed |
| WO-2010065446-A2 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2010-06-10 | — | — | WO | claimed |
| US-20100137178-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY | 2010-06-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137178-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | LMNA 2578/4885MAOA 45/4885MAOB 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.